Examples of 'anti-vegf antibody' in a sentence
Meaning of "anti-vegf antibody"
Anti-VEGF antibody is a type of medication that targets vascular endothelial growth factor (VEGF) to inhibit the growth of blood vessels, commonly used in treating certain eye conditions
How to use "anti-vegf antibody" in a sentence
Basic
Advanced
anti-vegf antibody
A specific example of an anti-VEGF antibody is bevacizumab.
The anti-VEGF antibody may be administered by intravenous administration.
In some embodiments the anti-VEGF antibody is bevacizumab.
The anti-VEGF antibody is bevacizumab and the chemotherapeutic is paclitaxel.
A method of making an anti-VEGF antibody is also provided.
The active agent in the composition is the anti-VEGF antibody.
More preferably the anti-VEGF antibody is bevacizumab or ranibizumab.
The example herein concerns an anti-VEGF antibody.
Examples of the anti-VEGF antibody may include bevacizumab.
In one embodiment the antibody is an anti-VEGF antibody.
In some examples, the anti-VEGF antibody is administered by intravenous administration.
Plates were then incubated with biotinylated polyclonal anti-VEGF antibody.
In some embodiments, the anti-VEGF antibody is administered by intravenous administration.
At least one active agent in the composition is an anti-VEGF antibody.
In some variations, the anti-VEGF antibody is administered by intravenous administration.
See also
In certain embodiments, resistant tumor is a tumor that is resistant to anti-VEGF antibody therapy.
In certain aspects, an anti-VEGF antibody is conjugated to a small molecule toxin.
The arrow indicates the band representing full length anti-VEGF antibody.
In certain aspects, the anti-VEGF antibody is conjugated to a small molecule toxin.
Será were taken from other animals for measurements of circulating anti-VEGF antibody.
In certain embodiments, the anti-VEGF antibody is bevacizumab or a fragment or variant thereof.
According to the invention, an obligatory chemotherapeutic agent in combination with a is an anti-VEGF antibody.
In certain embodiments, the humanized or variant anti-VEGF antibody is an antibody fragment.
Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer.
Is the most extensively utilized neutralizing anti-VEGF antibody in the literature to date.
An anti-VEGF antibody light chain variable domain comprising the amino acid sequence,.
In some variations, both the taxane and the anti-VEGF antibody are administered by intravenous administration.
The anti-VEGF antibody and the combination therapeutic agent can be administered simultaneously, sequentially or separately.
Suitable host cells for the expression of glycosylated anti-VEGF antibody are derived from multicellular organisms.
A preferred anti-VEGF antibody heavy chain variable domain comprises the amino acid sequence,.
In certain embodiments, the VEGF antagonist is an anti-VEGF antibody or fragment thereof.
In another embodiment, the anti-VEGF antibody is administered concurrently with said chemotherapeutic.
Antibody fragments In certain embodiments, the humanized or variant anti-VEGF antibody is an antibody fragment.
In certain embodiments, the anti-VEGF antibody administered to the patient is a monoclonal antibody.
In certain embodiments, subjects are previously treated with anti-VEGF antibody.
Examples of the anti-VEGF antibody may include bevacizumab and the like.
Tumor therapy with an anti-VEGF antibody.
An anti-VEGF antibody is marketed under the name of AVASTIN.
The taxane nanoparticle composition and the anti-VEGF antibody may be administered simultaneously to the individual.
Anti-VEGF antibody was administered as a positive control and the negative control was vehicle alone.
Bevacizumab is a full-length anti-VEGF antibody approved for use in metastatic colon cancer.
Anti-VEGF antibody compositions and methods.
In a specific embodiment, a patient treated with an anti-VEGF antibody of the disclosure has wet AMD.
Anti-VEGF antibody levels were analyzed through a laboratory ELISA.
In one embodiment, an anti-VEGF antibody is purified.
Anti-VEGF antibody inhibition and recombinant VEGF stimulation of angiogenic activity in vitro.
In certain embodiments, the anti-VEGF antibody is bevacizumab.
The anti-VEGF antibody of claim 1, wherein the anti-VEGF antibody is a humanized antibody.
In one embodiment, the anti-VEGF antibody is bevacizumab.
In one form of this implant, the antibody is an anti-VEGF antibody.
You'll also be interested in:
Examples of using Anti-vegf
Show more
A specific example of an anti-VEGF antibody is bevacizumab
The anti-VEGF antibodies of the disclosure can be humanized
These drugs are known as anti-VEGF agents
Examples of using Antibody
Show more
Antibody status should be monitored and reported
The kinetics of antibody decline are also similar
Antibody persistence after booster immunisation adults
